Digestive Function References

June 20, 2005 - Natural Products Industry INSIDER
"Digestive Function" References

1. Marteau P, Seksik P. "Tolerance of probiotics and prebiotics." JClin Gastroenterol. 38, 6 Suppl:S67-9, 2004.

2. Fedorak RN, Madsen KL. "Probiotics and prebiotics in gastrointestinaldisorders." Curr Opin Gastroenterol. 20, 2:146-55, 2004. www.co-gastroenterology.com

3. Gill HS, Guarner F. "Probiotics and human health: a clinicalperspective." Postgrad Med J. 80, 947-516-26, 2004. http://pmj.bmjjournals.com

4. Kaur N, Gupta AK. "Applications of inulin and oligofructose in healthand nutrition." J Biosci. 27, 7:703-14, 2002. www.ias.ac.in/jbiosci

5. Tokunaga T. "Novel physiological function offructooligosaccharides." Biofactors. 21, 1-4:89-94, 2004. www.iospress.nl/site/html/09516433.html

6. Manhart N et al. "Influence of fructooligosaccharides on Peyer'spatch lymphocyte numbers in health and endotoxemic mice." Nutrition.19, 7-8, 657-60, 2003. www.journals.elsevierhealth.com/periodicals/nut

7. Bouhnik Y et al. "The capacity of nondigestible carbohydrates tostimulate fecal bifidobacteria in healthy humans: a double blind, randomized,placebo-controlled, parallel-group, dose-response relation study." Am JClin Nutr. 80, 6:1658-64, 2004. www.ajcn.org

8. De Boever P, Deplancke B, Verstraete W. "Fermentation by gutmicrobiota cultured in a simulator of the human intestinal microbial ecosystemis improved by supplementing a soygerm powder." J Nutr.130:2599-2606, 2000. www.nutrition.org

9. Omogbenigum FO, Nyachoti CM, Slominski BA. "Dietary supplementationwith multienzyme preparations improves nutrient utilization and growthperformance in weaned pigs." J Anim Sci. 82, 4:1053-61, 2004. http://jas.fass.org

10. Li WF et al. "Effects of non-starch polysaccharides enzymes onpancreatic and small intestinal digestive enzyme activities in piglet fed dietscontaining high amounts of barley." World J Gastroenterol. 10,6:856-9, 2004. www.wjgnet.com

11. Cowieson AJ, Acamovic T, Bedford MR. "Supplementation of dietscontaining pea meal with exogenous enzymes: effects on weight gain, feedconversion, nutrient digestibility and gross morphology of the gastrointestinaltract of growing broiler chicks." Br Poult Sci. 44, 3:427-37, 2003.

12. Garcia MI et al. "Alpha-amylase supplementation of broiler dietsbased on corn." Poult Sci. 82, 3:436-42, 2003.

13. Frank LL et al. "The effects of a pre-exercise feeding with orwithout fungal carbohydrates (Carbogen) on blood parameters and exerciseperformance in elite cyclists: a preliminary study." Int J Sport NutrExercise Metab. 12:310-7, 2002.

14. Suarez F et al. "Pancreatic supplements reduce symptomatic responseof healthy subjects to a high fat meal." Dig Dis Sci. 44, 7:1317-21,1999. www.kluweronline.com/issn/0163-2116/current

15. Allen SJ et al. "Probiotics for treating infectious diarrhea." CochraneDatabase Syst Rev. 2:CD003048, 2004. www.cochrane.org

16. Benchimol EI, Mack DR. "Probiotics in relapsing and chronicdiarrhea." J Pediatr Hematol Oncol. 26, 8:515-7, 2004.

17. Plummer S et al. "Clostridium difficile pilot study: effects ofprobiotic supplementation on the incidence of C. difficile diarrhoea." IntMicrobiol. 7, 1:59-62, 2004.

18. Weizman Z, Asli G, Alsheikh A. "Effect of a probiotic infant formulaon infections in child care centers: a comparison of two probiotic agents."Pediatrics. 115, 1:5-9, 2005. www.pediatrics.org

19. Chouraqui JP, Van Egroo LD, Fichot MC. "Acidified milk formulasupplemented with bifidobacterium lactis: impact on infant diarrhea inresidential care settings." J Pediatr Gastroenterol Nutr. 38,3:288-92, 2004. www.jpgn.org

20. Thibault H, Aubert-Jacquin C, Goulet O. "Effects of long-termconsumption of a fermented infant formula (with Bifidobacterium breve c50 andStreptococcus thermophilus 065) on acute diarrhea in healthy infants." JPediatr Gastroenterol Nutr. 39, 2:147-52, 2004. www.jpgn.org

21. Meier R, Burri E, Steuerwald M. "The role of nutrition in diarrhoeasyndromes." Curr Opin Clin Nutr Metab Care. 6, 5:563-7, 2003. www.co-clinicalnutrition.com

22. La Rosa M et al. "[Prevention of antibiotic-associated diarrhea withLactobacillus sporogens and fructooligosaccharides in children. A multicentricdouble-blind vs placebo study.]" Minerva Pediatr. 55, 5:447-52,2003.

23. Kien CL et al. "Effects of prefeeding a prebiotic on diarrhea andcolonic cell proliferation in piglets fed lactulose." JPEN. 28,1:22-6, 2004. www.clinnutr.org/publications/journals/jpenabs.html

24. Rehman KU et al. "Gum arabic (GA) modifies paracellular water andelectrolye transport in the small intestine." Dig Dis Sci. 48,4:755-60, 2003. www.kluweronline.com/issn/0163-2116/current

25. Rehman KU, Codipilly CN, Wapnir RA. "Modulation of small intestinalnitric oxide synthase by gum arabic." Exp Biol Med (Maywood). 229,9:895-901, 2004. www.ebmonline.org

26. Bliss DZ et al. "Supplementation with dietary fiber improves fecalincontinence." Nurs Res. 50, 4:203-13, 2001.

27. Heiser CR et al. "Probiotics, soluble fiber, and L-glutamine (GLN)reduce nelfinavir (NFV)- or lopinavir/ritonavir (LPV/r)-related diarrhea." JInt Assoc Physicians AIDS Care (Chic Ill). 3, 4:121-9, 2004.

28. Coeffier M et al. "Effect of glutamine on water and sodiumabsorption in human jejunum at baseline and during PGE1-induced secretion."J Appl Physiol. 98, 6:2163-8, 2005. http://jap.physiology.org

29. Yalcin SS et al. "Effect of glutamine supplementation on diarrhea,interleukin-8 and secretory immunoglobulin A in children with acutediarrhea." J Pediatr Gastroenterol Nutr. 38, 5:494-501, 2004. www.jpgn.org

30. Bhatnagar S, Natchu UC. "Zinc in child health and disease." IndianJ Pediatr. 71, 11:991-5, 2004.

31. Alarcon K et al. "Effects of separate delivery of zinc or zinc andvitamin A on hemoglobin response, growth and diarrhea in young Peruvian childrenreceiving iron therapy for anemia." Am J Clin Nutr. 80, 5:1276-82,2004. www.ajcn.org

32. Bhatnagar S et al. "Zinc with oral rehydration therapy reduces stooloutput and duration of diarrhea in hospitalized children: a randomizedcontrolled trial." J Pediatr Gastroenterol Nutr. 38, 1:34-40, 2004. www.jpgn.org

33. Robberstad B et al. "Cost-effectiveness of zinc as adjunct therapyfor acute childhood diarrhoea in developing countries." Bull WorldHealth Organ. 82, 7:523-31, 2004.

34. Floch MH. "Use of diet and probiotic therapy in the irritable bowelsyndrome: analysis of the literature." J Clin Gastroenterol. 39, 5Suppl:S243-6, 2005.

35. Tsuchiya J et al. "Single blind follow-up study on the effectivenessof a symbiotic preparation in irritable bowel syndrome." Chin J Dig Dis.5, 4:169-74, 2004.

36. Saggioro A. "Probiotics in the treatment of irritable bowelsyndrome." J Clin Gastrenterol. 38, 6 Suppl:S104-6, 2004.

37. Kim HJ et al. "A randomized controlled trial of a probiotic, VSL#3,on gut transit and symptoms in diarrhoea-predominant irritable bowelsyndrome." Aliment Pharmacol Ther. 17, 7:895-904, 2003.

38. Weydert JA, Ball TM, Davis MF. "Systematic review of treatments forrecurrent abdominal pain." Pediatrics. 111, 1:e1-11, 2003. www.pediatrics.org

39. Kline RM et al. "Enteric-coated, pH-dependent peppermint oilcapsules for the treatment of irritable bowel syndrome in children." JPediatr. 138, 1:125-8, 2001. www.mosby.com/jpeds

40. Kanauchi O et al. "The beneficial effects of microflora, especiallyobligate anaerobes, and their products on the colonic environment ininflammatory bowel disease." Curr Pharm Des. 11, 8:1047-53, 2005.

41. Fedorak RN, Madsen KL. "Probiotics and the management ofinflammatory bowel disease." Inflamm Bowel Dis. 10, 3:286-99, 2004. www.ccfa.org/physician/table7.htm

42. Petrof EO et al. "Probiotics inhibit nuclear factor-kappaB andinduce heat shock proteins in colonic epithelial cells through proteasomeinhibition." Gastroenterology. 127, 5:1474-87, 2004. www.gastrojournal.org

43. Sartor RB. "Probiotic therapy of intestinal inflammation andinfections." Curr Opin Gastroenterol. 21, 1:44-50, 2005. www.co-gastroenterol.com

44. Lamine F et al. "Colonic responses to Lactobacillus farciministreatment in trinitrobenzene sulphonic acid-induced colitis in rats." ScandJ Gastroenterol. 39, 12:1250-8, 2004. www.tandf.co.uk/journals/titles/00365521.html

45. Pena JA et al. "Probiotic Lactobacillus spp. diminish Helicobacterhepaticus-induced inflammatory bowel disease in interleukin-10-deficientmice." Infect Immun. 73, 2:912-20, 2005. http://iai.asm.org

46. Kato K et al. "Randomized placebo-controlled trial assessing theeffect of bifidobacteria-fermented milk on active ulcerative colitis." AlimentPharmacol Ther. 20, 10:1133-41, 2004.

47. Laake KO et al. "Outcome of four weeks' intervention with probioticson symptoms and endoscopic appearance after surgical reconstruction with aJ-configurated ileal-pouch-anal-anastomosis in ulcerative colitis." ScandJ Gastroenterol. 40, 1:43-51, 2005. www.tandf.co.uk/journals/titles/00365521.html

48. Gosselink MP et al. "Delay of the first onset of pouchitis by oralintake of the probiotic strain Lactobacillus rhamnosus GG." Dis ColonRectum. 47, 6:876-84, 2004.

49. Cui HH et al. "Effects of probiotic on intestinal mucosa of patientswith ulcerative colitis." World J Gastroenterol. 10, 10:1521-5,2004. www.wjgnet.com

50. Furrie E et al. "Synbiotic therapy (Bifidobacterium longum/Synergy1) initiates resolution of inflammation in patients with active ulcerativecolitis: a randomized controlled pilot trial." Gut. 54, 2:242-9,2005. http://gut.bmjjournals.com

51. Cherbut C, Michel C, Lecannu G. "The prebiotic characteristics offructooligosaccharides are necessary for reduction of TNBS-induced colitis inrats." J Nutr. 1331, 1:21-7, 2003. www.nutrition.org

52. Bamba T et al. "A new prebiotic from germinated barley fornutraceutical treatment of ulcerative colitis." J Gastroenterol Hepat.17, 8:818-24, 2002.

53. Kanauchi O et al. "Treatment of ulcerative colitis patients bylong-term administration of germinated barley foodstuff: multi-center opentrial." Int J Mol Med. 12, 5:701-4, 2003. http://virology.med.uoc.gr/IJMM/ijmm.htm

54. Oz HS et al. "Antioxidants as novel therapy in a murine model ofcolitis." J Nutr Biochem. 16, 5:297-304, 2005. www.elsevier.com/locate/jnutbio

55. Ademoglu E et al. "Do vitamin E and selenium have beneficial effectson trinitrobenzenesulfonic acid-induced experimental colitis." Dig DisSci. 49, 1:102-8, 2004. www.kluweronline.com/issn/0163-2116/current

56. Langmead L, Makins RJ, Rampton DS. "Anti-inflammatory effects ofaloe vera gel in human colorectal mucosa in vitro." Aliment PharmacolTher. 19, 5:521-7, 2004.

57. Langmead L et al. "Randomized, double blind, placebo-controlledtrial of oral aloe vera gel for active ulcerative colitis." AlimentPharmacol Ther. 19, 7:739-47, 2004.

58. Korkina L et al. "The protective and healing effects of a naturalantioxidant formulation based on ubiquinol and Aloe vera against dextransulfate-induced ulcerative colitis in rats." Biofactors. 18,1-4:255-64, 2003. www.iospress.nl/site/html/09516433.html

59. Winter TA et al. "Impaired gastric acid and pancreatic enzymesecretion in patients with Crohn's disease may be a consequence of a poornutritional state." Inflamm Bowel Dis. 10, 5:618-25, 2004. www.ccfa.org/physician/table7.htm

60. Chowers Y et al. "Increased levels of homocysteine in patients withCrohn's disease are related to folate levels." Am J Gastroenterol.95, 12:3498-502, 2000. www.amjgastro.com

61. Vestergaard P. "Prevalence and pathogenesis of osteoporosis inpatients with inflammatory bowel disease." Minerva Med. 95,6:469-80, 2004.

62. Griffin IJ et al. "Zinc metabolism in adolescents with Crohn'sdisease." Pediatr Res. 56, 2:235-9, 2004. www.pedresearch.org

63. Sturniolo GC et al. "Zinc supplementation tightens 'leaky gut' inCrohn's disease." Inflamm Bowel Dis. 7, 2:94-8, 2001. www.ccfa.org/physician/table7.htm

64. Thomas PD, Nichols TW, Angstadt A. "Dietary bioactive peptides inmaintaining intestinal integrity and function." Am J Gastroenterol.96, 9:S311, 2001. www.amjgastro.com

65. Nichols TW et al. "Preliminary reports: Improvement in mucosalintegrity in IBD patients and reduction in GI symptoms in HIV patients withhydrolyzed white fish." Peptides. 108, 1:31, 2002. www.sciencedirect.com/science/journal/01969781

66. Fitzgerald AJ et al. "Reparative properties of a commercial fishprotein hydrolysate preparation." Gut. 54, 6:775-81, 2005. http://gut.bmjjournals.com

67. Sjunnesson H et al. "High intake of selenium, beta-carotene andvitamins A, C and E reduces growth of Helicobacter pylori in the guineapig." Comp Med. 51, 5:418-23, 2001.

68. Ustundag Y et al. "Plasma and gastric tissue selenium levels inpatients with Helicobacter pylori infection." J Clin Gastroenterol.32, 5:405-8, 2001.

69. Wang X, Willen R, Wadstrom T. "Astaxanthin-rich algal meal andvitamin C inhibit Helicobacter pylori infection in BALB/cA mice." AntimicrobAgents Chemother. 44, 9:2452-7, 2000. http://aac.asm.org

70. Bennedsen M et al. "Treatment of H. pylori infected mice withantioxidant astaxanthin reduces gastric inflammation, bacterial load andmodulates cytokine release by splenocytes." Immunol Lett. 70,3:185-9, 1999.

71. Kim JH et al. "Protective effect of astaxanthin on naproxen-inducedgastric antral ulceration in rats." Eur J Pharmacol. 514, 1:53-9,2005.

72. Akyon Y. "Effect of antioxidants on the immune response ofHelicobacter pylori." Clin Microbiol Infect. 8, 7:438-41, 2002.

73. Simon JA, Hudes ES, Perez-Perez GI. "Relation of serum ascorbic acidto Helicobacter pylori serology in U.S adults: the Third National Health andNutrition Examination Survey." J Am Coll Nutr. 22, 4:283-9, 2003. www.jacn.org

74. Park JH et al. "Correlation between Helicobacter pylori infectionand vitamin C levels in whole blood, plasma and gastric juice, and the pH ofgastric juice in Korean children." J Pediatr Gastroenterol Nutr. 37,1:53-62, 2003. www.jpgn.org

75. Sasazuki S et al. "The effect of 5-year vitamin C supplementation onserum pepsinogen level and Helicobacter pylori infection." Cancer Sci. 94,4:378-82, 2003.

76. Smith GV, Farthing MJ. "The effect of ascorbic acid on Helicobacterpylori-induced cyclooxygenase 2 expression and prostaglandin E2 production bygastric epithelial cells in vitro." Helicobacter. 10, 1:83-9, 2005.

77. Zhang ZW, Abdullahi M, Farthing MJ. "Effect of physiologicalconcentrations of vitamin C on gastric cancer cells and Helicobacterpylori." Gut. 50, 2:165-9, 2002. http://gut.bmjjournals.com

78. Borrelli F, Izzo AA. "The plant kingdom as a source of anti-ulcerremedies." Phytother Res. 14, 8:581-91, 2000. www.interscience.wiley.com/jpages/0951-418X

79. Yusuf S, Agunu A, Diana M. "The effect of Aloe vera A. Berger(Liliaceae) on gastric acid secretion and acute gastric mucosal injury inrats." J Ethnopharmacol. 93, 1:33-7, 2004. www.elsevier.nl/inca/publications/store/5/0/6/0/3/5

80. Sivan GP. "Protection against Helicobacter pylori and otherbacterial infections by garlic." J Nutr. 131, 3 Supp:1106S-8S, 2001.www.nutrition.org

81. Imai H et al. "Inhibition by the essential oils of peppermint andspearmint of the growth of pathogenic bacteria." Microbios. 106,Suppl 1:31-9, 2001.

82. Mahady GB et al. "Ginger (Zingiber officinale Roscoe) and thegingerols inhibit the growth of Cag A+ strains of Helicobacter pylori." AnticancerRes. 23, 5A:3699-702, 2003. www.geocities.com/Athens/Rhodes/8729/iiar/iiar.htm

83. Ishihara R et al. "Polaprezinc attenuates Helicobacterpylori-associated gastritis in Mongolian gerbils." Helicobacter. 7,6:384-9, 2002.

84. Suzuki H et al. "Polaprezinc attenuates the Helicobacterpylori-induced gastric mucosal leucocyte activation in Mongolian gerbils--astudy using intravital videomicroscopy." Aliment Pharmacol Ther. 15,5:715-25, 2001.

85. Korolkiewicz R et al. "Polaprezinc exerts a salutary effect onimpaired healing of acute gastric lesions in diabetic rats." Dig Dis Sci.45, 6:1200-9, 2000. www.kluweronline.com/issn/0163-2116/current

86. Naito Y et al. "Effects of polaprezinc on lipid peroxidation,neutrophil accumulation, and TNF-alpha expression in rats with aspirin-inducedgastric mucosal injury." Dig Dis Sci. 46, 4:845-51, 2001. www.kluweronline.com/issn/0163-2116/current

87. Hamilton-Miller JM. "The role of probiotics in the treatment andprevention of Helicobacter pylori infection." Int J Antimicrob Agents.22, 4:360-6, 2003.

88. Felley C, Michetti P. "Probiotics and Helicobacter pylori." BestPract Res Clin Gastroenterol. 17, 5:785-91, 2003.

89. Nista EC et al. "Bacillus clausii therapy to reduce side-effects ofanti-Helicobacter pylori treatment: randomized, double-blind, placebo controlledtrial." Aliment Pharmacol Ther. 20, 10:1181-8, 2004.

90. Tursi A et al. "Effect of Lactobacillus casei supplementation on theeffectiveness and tolerability of a new second-line 10-day quadruple therapyafter failure of a first attempt to cure Helicobacter pylori infection." MedSci Monit. 10, 12:CR662-6, 2004.

91. Armuzzi A et al. "The effect of oral administration of LactobacillusGG on antibiotic-associated gastrointestinal side-effects during Helciobacterpylori eradication therapy." Aliment Pharmacol Ther. 15, 2:163-9,2001.

92. Dial EJ et al. "Recombinant human lactoferrin prevents NSAID-inducedintestinal bleeding in rodents." J Pharm Pharmacol. 57, 1:93-9,2005. http://jpp.pharmpress.com/content/html/index.htm

93. Seganti L et al. "Antiviral activity of lactoferrin towards nakedviruses." Biometals. 17, 3:295-9, 2004.

94. Griffiths EA et al. "In vitro growth responses of bifidobacteria andenteropathogens to bovine and human lactoferrin." Dig Dis Sci. 48,7:1324-32, 2003. www.kluweronline.com/issn/0163-2116/current